CTCL: Shortening the Diagnostic Journey and Starting Treatment Early
Yuliya Linhares, MD, Chief of Lymphoma Services at Miami Cancer Institute, discusses strategies for shortening the diagnostic journey of CTCL.
Related Articles
Rare Disease Recognition and Awareness Days
Stay informed with our comprehensive calendar of rare disease awareness days, highlighting key dates and resources.
A Family’s Experience With ALSP
Erin Sullivan, Executive Director of Sisters’ Hope Foundation, discusses her family’s experience with ALSP.
Genetic Testing for WHIM Syndrome
Jolan Walter, PhD, MD, Division Chief of Pediatric Allergy and Immunology at the University of South Florida, discusses genetic testing for WHIM syndrome.
The Current Landscape of SYNGAP1-Related Disorders
Mike Graglia, Co-Founder & Managing Director of the SynGAP Research Fund, discusses the current landscape of SYNGAP1-related disorders (SRD).
Video Conferencing, Web Conferencing, Webinars, Screen Sharing
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile,…
Repurposing Shelved Assets for Rare Diseases
Annette Bakker, PhD, Chief Executive Officer of the Children’s Tumor Foundation, discusses repurposing shelved assets for rare diseases.
The Undiagnosed Disease Network
Kimberly LeBlanc, Director of the Undiagnosed Diseases Network Coordinating Center, discusses approaching variants of uncertain significance.
Phase 3 Studies Lead to Approval of Fitusiran for Hemophilia A and B
Sanjay Ahuja, MD, Pediatric Hematologist, discusses the FDA approval of Qfitlia (fitusiran) for patients with hemophilia A or B.
2025 Orphan Drugs: PDUFA Dates and FDA Approvals
Almost half of all novel medications approved by the U.S. Food and Drug Administration (FDA) are orphan drugs. Below is the list of important regulatory…
Immunoglobulin A Nephropathy Study | See If You May Qualify | I CAN Study
Learn more about a clinical research study for adults living with immunoglobulin A nephropathy. Complete the questionnaire to see if you may qualify for the…